UNSPSC 51312811: Fenethazine hydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H18N2S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 225AVG0161, chemically known as 10h-phenothiazine-10-ethanamine, n,n-dimethyl-, monohydrochloride but more generally known as fenethazine hydrochloride, which bears US NIH Compound Identifier 68223. Most nations, for tariff and trade purposes, schedule fenethazine hydrochloride under HS 29343090 and SITC 51578.

As of Q4 2014, FENETHAZINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CN(C)CCN1C2CCCCC2SC3C1CCCC3.CL.

UNSPSC 51312811 Fenethazine hydrochloride is a Commodity code, but state and local procurement activity under this specific code shows minimal relevance to recent solicitations. The three most recent opportunities tagged to this code — a Seminole County naloxone and drug-deactivation system procurement, a Texas HHS direct-to-manufacturer prescription initiative, and a Minnesota multistate cooperative purchasing agreement for generic pharmaceuticals and OTC products — are nominally pharmaceutical-related but involve product categories, sourcing models, and delivery mechanisms that diverge substantially from a single-ingredient pharmaceutical compound. Seminole County's IFB60459723LAS solicits naloxone units and safe drug deactivation systems as discrete health-response products with quarterly delivery to a county health building; Texas HHS0017013 is an exploratory Request for Information on direct manufacturer contracting models rather than procurement of specific drug products; and the Minnesota MMCAP RFP S1070000015802 covers multi-source generics and OTC items through authorized wholesalers with manufacturer pricing and NDC-based specifications. None of these opportunities explicitly reference fenethazine hydrochloride or compounds within its therapeutic class, and the procurement structures (volume-based county health procurement, state pharmacy benefit design, and multistate cooperative generic contracting) do not align with sourcing patterns for single-ingredient pharmaceutical commodities.

The issuing bodies — Seminole County (Florida), the Texas Health and Human Services Commission, and the Minnesota Department of Administration via its multistate cooperative — span state health agencies, county health departments, and cooperative purchasing vehicles serving multiple jurisdictions, but the geographic and scope signals are too divergent to characterize fenethazine hydrochloride activity specifically. Recent state and local procurement under this code shows no targeted demand for this commodity.